Please note that eDoc will be permanently shut down in the first quarter of 2021!      Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Quick Search
My eDoc
Session History
Support Wiki
Direct access to
document ID:

          Institute: MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut)     Collection: Yearbook_2015     Display Documents

ID: 711846.0, MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut) / Yearbook_2015
Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysema
Authors:Weissmann, N.; Lobo, B.; Pichl, A.; Parajuli, N.; Seimetz, M.; Puig-Pey, R.; Ferrer, E.; Peinado, V. I.; Dominguez-Fandos, D.; Fysikopoulos, A.; Stasch, J. P.; Ghofrani, H. A.; Coll-Bonfill, N.; Frey, R.; Schermuly, R. T.; Garcia-Lucio, J.; Blanco, I.; Bednorz, M.; Tura-Ceide, O.; Tadele, E.; Brandes, R. P.; Grimminger, J.; Klepetko, W.; Jaksch, P.; Rodriguez-Roisin, R.; Seeger, W.; Grimminger, F.; Barbera, J. A.
Date of Publication (YYYY-MM-DD):2014-06-01
Title of Journal:Am J Respir Crit Care Med
Issue / Number:11
Start Page:1359
End Page:1373
Audience:Not Specified
Abstract / Description:RATIONALE: Chronic obstructive pulmonary disease (COPD) is a major cause of death worldwide. No therapy stopping progress of the disease is available. OBJECTIVES: To investigate the role of the soluble guanylate cyclase (sGC)-cGMP axis in development of lung emphysema and pulmonary hypertension (PH) and to test whether the sGC-cGMP axis is a treatment target for these conditions. METHODS: Investigations were performed in human lung tissue from patients with COPD, healthy donors, mice, and guinea pigs. Mice were exposed to cigarette smoke (CS) for 6 hours per day, 5 days per week for up to 6 months and treated with BAY 63-2521. Guinea pigs were exposed to CS from six cigarettes per day for 3 months, 5 days per week and treated with BAY 41-2272. Both BAY compounds are sGC stimulators. Gene and protein expression analysis were performed by quantitative real-time polymerase chain reaction and Western blotting. Lung compliance, hemodynamics, right ventricular heart mass alterations, and alveolar and vascular morphometry were performed, as well as inflammatory cell infiltrate assessment. In vitro assays of cell adhesion, proliferation, and apoptosis have been done. MEASUREMENTS AND MAIN RESULTS: The functionally essential sGC beta1-subunit was down-regulated in patients with COPD and in CS-exposed mice. sGC stimulators prevented the development of PH and emphysema in the two different CS-exposed animal models. sGC stimulation prevented peroxynitrite-induced apoptosis of alveolar and endothelial cells, reduced CS-induced inflammatory cell infiltrate in lung parenchyma, and inhibited adhesion of CS-stimulated neutrophils. CONCLUSIONS: The sGC-cGMP axis is perturbed by chronic exposure to CS. Treatment of COPD animal models with sGC stimulators can prevent CS-induced PH and emphysema.
Free Keywords:Animals; Biological Markers/metabolism; Blotting, Western; Disease Models, Animal; Down-Regulation; Emphysema/enzymology/*prevention & control; Guanylate Cyclase/*metabolism; Guinea Pigs; Humans; Hypertension, Pulmonary/enzymology/*prevention & control; In Vitro Techniques; Mice; Pulmonary Disease, Chronic Obstructive/enzymology/*prevention & control; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear/*metabolism; Smoking/*adverse effects/metabolism
External Publication Status:published
Document Type:Article
Communicated by:MPI für Herz- und Lungenforschung
Affiliations:MPI für physiologische und klinische Forschung
External Affiliations:%^ 1435822045
Identifiers:ISSN:1535-4970 (Electronic) 1073-449X (Linking) %R 10.1164/rccm.201311-2037OC
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.